Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Pliant Therapeutics Stock

Q: How to sell Pliant Therapeutics stock?

If you hold private company shares of Pliant Therapeutics - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Pliant Therapeutics stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

pliantrx.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $187MM

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.

Buy or sell Pliant Therapeutics stockLearn more about Pliant Therapeutics IPO

OverviewFinancingsValuation

Enterprise Value

Access Pliant Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pliant Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Bernard Coulie MD

Chief Executive Officer, President & Board Member

Hans Hull JD

Chief Business Officer

Dean Sheppard MD

Scientific Founder and Scientific Advisor, Translational Medicine

Barbara Howes

Chief Human Resources Officer

Éric Lefebvre MD

Chief Medical Officer

Hal Chapman MD

Scientific Founder and Scientific Advisor, Translational Medicine

Keith Cummings MD

Chief Financial Officer

Rik Derynck Ph.D

Scientific Co-Founder & Scientific Advisor of Biology

William DeGrado Ph.D

Scientific Founder

Board Members

John Curnutte MD

Neil Exter

Third Rock Ventures

Hoyoung Huh Ph.D

Kevin Raidy

Cowen Group

Suzanne Bruhn Ph.D

Craig Muir

Third Rock Ventures

Smital Shah

Charles Homcy MD

Third Rock Ventures

Pliant Therapeutics stock FAQs

Can you buy Pliant Therapeutics stock?

As Pliant Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Pliant Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Pliant Therapeutics stock?

To invest in a private company like Pliant Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Pliant Therapeutics stock?

Yes, you may be able to sell your Pliant Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Pliant Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Pliant Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Pliant Therapeutics a public company?

No, Pliant Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Pliant Therapeutics’ stock price?

Pliant Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Pliant Therapeutics’ private market stock price with Forge Data.

What is Pliant Therapeutics’ stock ticker symbol?

Pliant Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Fierce Biotech 10/23/2019

Novartis bets $80M on Pliant's preclinical NASH prospect

Novartis has put up $80 million to land the global license to Pliant Therapeutics’ preclinical nonalcoholic steatohepatitis (NASH) asset and three additional candidates. The NASH drug, PLN-1474, is a small molecule inhibitor of integrin αVβ1 Pliant thinks can reduce the growth of fibrotic tissue in the liver.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Pliant Therapeutics Stock

Register To Buy and Sell Shares

Enterprise Value

Access Pliant Therapeutics’ valuation and stock price.

Team

Management Team

Board Members

Pliant Therapeutics stock FAQs

Can you buy Pliant Therapeutics stock?

How to buy Pliant Therapeutics stock?

Can you sell Pliant Therapeutics stock?

How to sell Pliant Therapeutics stock?

Is Pliant Therapeutics a public company?

What is Pliant Therapeutics’ stock price?

What is Pliant Therapeutics’ stock ticker symbol?

Can institutional investors buy and sell private market stocks?

Other companies like Pliant Therapeutics in the BioTech & Pharma sector

Novartis bets $80M on Pliant's preclinical NASH prospect

Frequently Asked Questions

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES